Overview

A Safety and Efficacy Trial of a Treat and Extend Protocol Using Ranibizumab With and Without Laser Photocoagulation for Diabetic Macular Edema

Status:
Completed

Trial end date:
2018-04-01

Target enrollment:

Participant gender:

Summary

The purpose of this research study is to determine if a "Treat and Extend" regimen (increasing the time between visits when the disease is stable and not getting worse) of Ranibizumab 0.3 mg injections inside the eye is safe and effective at treating patients with swelling of the retina from diabetes.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Palmetto Retina Center, LLC

Treatments:

Ranibizumab